1,017
Participants
Start Date
April 20, 2021
Primary Completion Date
March 31, 2023
Study Completion Date
December 31, 2024
Primary exposure is hypoxia (no intervention)
The primary exposure, hypoxia, will be defined as severe, non-severe or none for each participant, based on pre-defined criteria.
FioCruz, Recife
National Institute of Mental Health and Neurosciences, Bangalore
Christian Medical College, Vellore
Malawi Liverpool Wellcome Clinical Research Programme, Blantyre
Kamuzu University of Health Sciences, Blantyre
Christian Medical College, Vellore, India
OTHER
Instituto Autoimune, Brazil
UNKNOWN
University College London Hospitals
OTHER
Oswaldo Cruz Foundation
OTHER
Kamuzu University of Health Sciences
OTHER
National Institute of Mental Health and Neuro Sciences, India
OTHER
Encephalitis Society, UK
UNKNOWN
University of Liverpool
OTHER